3-[2-(2-Ethoxycarbonyl-ethoxy)-ethoxy]-propionic acid, 97.0%, 250mg

5-Bromo-3-fluoro-2-iodophenol, 97%, 1g

2H-Imidazo[4,5-c]quinolin-2-one, 7-(3,5-dimethyl-4-isoxazolyl)-1,3-dihydro-8-methoxy-1-[(1R)-1-(2-pyridinyl)ethyl]-, 98%, 10mg

Objectif EPLPH phase E-Plan 10x/0,25. Distance de travail 6,61 mm

Methyl 2-Fluoronicotinate, 97.0%, 25g

3-(2-Thienyl)-3-[(2,2,2-trifluoroacetyl)amino]propanoic acid, 95.0%, 1g

4-Isopropoxyphenol, 95.0%, 5g

1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-(methylamino)piperidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, 98.0%, 100mg

CompactDry X-BC, 240 pièces

Tubes à essai ROTILABO® Verre brun, 4 ml, 100 Pièce(s)

1-(2-fluorophenyl)-5-phenyl-4,5-dihydro-1H-pyrazole-3-carboxylic acid, 95.0%, 5g

Pipette microlitre monocanal Acura® variable manuelle, 0,5 à 10 µl, 825, 1 pièce

7-Methyl-imidazo[1,2-a]pyridine-2-carboxylic acidethyl ester, 95.0%, 5g